Search Results 141-150 of 5416 for edward loftus

  1. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

    Edward Loftus, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...

  2. Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Contact information: Troy Ofstie R.N., CCRP. (507) 266-4728. Contact UsIBDresearch@mayo.edu. Open for enrollment. More information ...

  3. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  4. A 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Contact information: Troy Ofstie R.N., CCRP. (507) 266-4728. Contact UsIBDresearch@mayo.edu. Contact us for the latest status. More ...

  5. Neurosurgery - Doctors - Mayo Clinic

    Edward S. Ahn, M.D.. Pediatric Neurosurgeon. Rochester, MN ...

  6. Foot and ankle care: From sports medicine to complex anomalies - Mayo Clinic

    "We are committed to providing destination medical center care, regardless of the complexity of the injury," says Edward T. Haupt, M.D., an orthopedic ...

  7. Mayo Clinic Faculty Profiles

    Ahn, Edward S. M.D. · Ailawadhi, Sikander M.D. · Akhoundi, Abbasali M.D. · Akkus, Zeynettin Ph.D. Alavi, Afsaneh M.D. · Alberts, Steven R. M.D., M.P.H. ...

  8. Publications - Michael C. Stephens, M.D. - Mayo Clinic

    Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, ...

  9. An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  10. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...